Research And Development Tenders

Dbs Sun Protection for Various Properties

Openhouse Procedure - Div. Active Substances from 01.10.2023

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Leflunomide, Atc Code: L04aa13 for the Period from October 1St, 2023 to September 30Th, 2025

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Oxycodone, Naloxone (Patent-Free Indication), Atc Code: N02aa55 for the Period from October 1St, 2023 to September 30Th, 2025

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Buserelin, Atc Code: L02ae01 for the Period from October 1St, 2023 to September 30Th, 2025

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Teriflunomide, Atc Code: L04aa31 for the Period from October 1St, 2023 to September 30Th, 2025

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Formoterol, Atc Code: R03ac13 for the Period from October 1St, 2023 to September 30Th, 2025

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Diclofenac, Atc Code: D11ax18 for the Period from October 1St, 2023 to September 30Th, 2025

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Sapropterin, Atc Code: A16ax07 for the Period from October 1St, 2023 to September 30Th, 2025